Join our growing community to challenge mainstream media bias and fix the news
Johnson & Johnson’s single-shot Covid-19 vaccine shows less efficacy than others

Johnson & Johnson’s single-shot Covid-19 vaccine shows less efficacy than others

After conducting large-scale trials across three continents and against multiple variants of the novel coronavirus, Johnson & Johnson said its single-dose vaccine was 72% effective in preventing the virus in the United States and 66% overall. Those results are significantly lower than the high rate of efficacy of the two-dose vaccines from Pfizer Inc/BioNTech and Moderna, which are around 95%.

Timothy
Timothy
Kurt
Kurt 2 months

So we should take a shot that has been given emergency authorization, which is 70% or less effective for a disease that has at least a 98% survival rate IF you happen to contract the disease in spite of the masks and lockdowns? 👌🏼

Quang
Quang 2 months

The timing of the study is different from the mRNA vaccines so it's not an apples to apples comparison. The vaccines effectiveness in reducing severe cases is very promising let alone the reduced chance for human error since it doesn't require deep freeze storage. The title is misleading.

Skot
Skot 2 months

Which is to say, less than worthless.

hooman of hoomanland
hooman of hoomanland 2 months

It’s all emergency use right now but it will be sad if insurance company’s only cover the less effective one, can anyone comment on if ‘less efficacy=cheaper’ in this case?

Paul N
Paul N 2 months

If everyone gets the shot they will all be immune so that means I don’t need one. Perfect!

Patrick
Patrick 2 months

Throw it away! I'm sure they'll get a piece of this massively profitable BS though. Cronyism at it's finest right here. They'll dump this crap on the rest of America... "here ya go chump, you get the garbage. Stay safe!"

Andromeda
Andromeda 2 months

It also has a side effect of "no more tears"

KarmaDharma
KarmaDharma 2 months

It’s not worthless. Gosh! Read the whole article. “Johnson & Johnson’s vaccine is a single shot rather than a two-course treatment, which should make it much easier to distribute much more quickly. The vaccine also showed 100% efficacy in preventing hospitalization or death among participants in the trial, 28 days after vaccination, which is a key measure when considering the broader impact of COVID-19 on healthcare resources.”

Andrew
Andrew 2 months

Anyone want to take a stab at how effective the standard flu shot is? 40%-60%... and it’s pushed non stop, every year. Even required by many employers. But 60%+ is too low and is worthless all of a sudden?

Top in Business